pedCAPNETZ - Community Acquired Pneumonia (CAP) in Childhood and Adolescence
pedCAPNETZ
pedCAPNETZ - Development and Detailed Characterization of a Cohort for Community Acquired Pneumonia (CAP) in Childhood and Adolescence
1 other identifier
observational
1,000
1 country
1
Brief Summary
Establishment of a study network and patient cohort for pediatric CAP
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 18, 2014
CompletedFirst Submitted
Initial submission to the registry
May 16, 2019
CompletedFirst Posted
Study publicly available on registry
August 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedNovember 6, 2019
November 1, 2019
9 years
May 16, 2019
November 5, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Number of patients with pediatric community acquired pneumonia (pedCAP) across all different levels of health care
To establish a multicenter national, prospective, observational and longitudinal pedCAP database and collaborative research network
5 years
Prevalence of pedCAP and etiologies (composite outcome measures) across all different levels of health care
* Etiology of pedCAP in Germany * Clinical presentation of pedCAP * Predictors of severe clinical course of pedCAP * Diagnostics employed in management of pedCAP * Microbiology and virology of pedCAP * Radiology of pedCAP * Comorbidity in patients with pedCAP * Treatment patterns of pedCAP
5 years
Eligibility Criteria
CAP patients age \< 18
You may qualify if:
- age \< 18
- symptoms of an acute lower respiratory tract infection with radiological confirmed pneumonia via ultrasound or chest x-ray
You may not qualify if:
- hospitalization for any reason within the last 28 days
- congenital or acquired immunodeficiency
- concomitant respiratory disease with impaired mucociliary clearance such as cystic fibrosis, primary ciliary dyskinesia, tracheostomy or other severe lung disease including pulmonary tuberculosis, malignancy, and cytostatic therapy during past 28 days or neutropenia (\< 1000/µl) or relevant immunosuppressive treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medizinische Hochschule Hannover
Hanover, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2019
First Posted
August 6, 2019
Study Start
December 18, 2014
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
November 6, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share